<html><body><h2>Case: 1577756</h2><h3> CDS Time: 1967-04-11</h3>
<patient name=1577756>
67.0 year old Asian_or_Pacific-Islander_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">67</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">89</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">5</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">68</td><td width="200">1966-5-7</td></tr>
<tr><td width="200">Chloride</td><td width="200">94.0</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">59</td><td width="200">1966-5-7</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">51</td><td width="200">1967-4-2</td></tr>
<tr><td width="200">BNP</td><td width="200">12,537</td><td width="200">1967-4-2</td></tr>
<tr><td width="200">B 12</td><td width="200">936.0</td><td width="200">1967-1-13</td></tr>
<tr><td width="200">Weight</td><td width="200">115</td><td width="200">1967-4-2</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">45</td><td width="200">1966-5-7</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">136</td><td width="200">1966-5-7</td></tr>
<tr><td width="200">SGOT</td><td width="200">57</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">92</td><td width="200">1967-4-2</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">11</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Height</td><td width="200">58</td><td width="200">1967-4-2</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">136</td><td width="200">1966-5-7</td></tr>
<tr><td width="200">BUN</td><td width="200">76</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">HCT</td><td width="200">24</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">HGB</td><td width="200">8</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Sodium</td><td width="200">131</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Albumen</td><td width="200">2</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Creatinine</td><td width="200">3.0</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Pulse</td><td width="200">82</td><td width="200">1967-4-2</td></tr>
<tr><td width="200">PLT</td><td width="200">97</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">WBC</td><td width="200">20</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">eGFR</td><td width="200">26</td><td width="200">1966-12-16</td></tr>
<tr><td width="200">SGPT</td><td width="200">33</td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1967-4-6</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1967-4-11</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1966-12-13</td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1967-3-11</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1967-4-10</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1966-12-13</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1966-12-15</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1967-4-11</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1966-9-3</td></tr>
<tr><td width="200">Pacemaker</td><td width="200"></td><td width="200">1967-4-6</td></tr>
<tr><td width="200">Sinoatrial node dysfunction</td><td width="200"></td><td width="200">1967-1-23</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1967-4-8</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1967-4-8</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1967-4-10</td></tr>
</table>
<p><b>Medications:</b> propranolol(30.0) losartan(50.0) spironolactone(25.0) atenolol(25.0) lisinopril(5.0) furosemide(100.0) lovastatin(20.0) Insulin(10.0) bumetanide(1.0) torsemide(60.0) atorvastatin(20.0) carvedilol(3.125) hydrochlorothiazide(50.0) amiodarone(200.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Sinoatrial node dysfunction</td>
<td width="200">1967-01-23</td>
<td width="200"> Sinoatrial node dysfunction()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyponatremia[Sodium(131.0/1967-4-10)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(3.0/1967-4-10)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">On Amiodarone</td>
<td width="200"></td>
<td width="200"> Amiodarone[amiodarone]()</td></tr>
<tr><td width="200">HCTZ >25mg</td>
<td width="200"></td>
<td width="200"> HCTZ >25mg[hctz >25mg]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(92/null) && presence of heart failure]()</td></tr>
<tr><td width="200">MI (secondary prevention) BP controlled</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction (Secondary Prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(92/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(92/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(67.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of lipid disorder ICD9]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(26.0/1966-12-16)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(26.0/1966-12-16)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(67.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.2/1967-4-10) && presence of MI]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">Acitve prescription for ACE and ARB</td>
<td width="200"></td>
<td width="200"> Acitve prescription for ACE and ARB[ACE I being used && Presence of ARB]()</td></tr>
<tr><td width="200">Active prescription for ACE and aldosterone antagonists</td>
<td width="200"></td>
<td width="200"> Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Active prescription for ARB and aldosterone antagonist</td>
<td width="200"></td>
<td width="200"> Active prescription for ARB and aldosterone antagonist[Presence of ARB && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Female and most recent creatinine  >2</td>
<td width="200"></td>
<td width="200"> Female and most recent creatinine  >2[Sex(Female) && Creatinine(3.0/1967-4-10)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1967-04-08</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-04-08</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1967-04-11</td>
<td width="200"> Liver_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGOT(57.0/1967-4-10)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1967-04-10</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-04-10</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-03-11</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-04-06</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-01-23</td>
<td width="200"> Sinoatrial node dysfunction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-04-11</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1966-12-15</td>
<td width="200"> Hypertension()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.2/1967-4-10) && presence of MI]()</td></tr>
<tr><td width="200">Pacemaker</td>
<td width="200">1967-04-06</td>
<td width="200"> Pacemaker()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1966-12-13</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.2/1967-4-10) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1966-12-13</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1966-09-03</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: aspirin Reaction: 
<li>Substance: aspirin Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
<li>Test: [because <i> On ACEI, ARB and aldosterone antagonist </i> evaluate to <b>true</b><i>(Presence of ACE Inhibitor && Presence of ARB && presence of aldosterone antagonist)</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(68.0/1966-5-7))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(51/null) && Treatment_Systolic_BP(92/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
<li>Patients who have not developed HF symptoms should be treated according to contemporary guidelines after an acute MI. (Level of Evidence: C).
</ul>
<li><b>Class III</b>
<ul>
<li>Routine combined use of an ACEI, ARB, and aldosterone antagonist is NOT RECOMMENDED for patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: C)
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

Routine combined use of an ACEI, ARB, and aldosterone antagonist is NOT RECOMMENDED for patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: C)
<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
Patients who have not developed HF symptoms should be treated according to contemporary guidelines after an acute MI. (Level of Evidence: C).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>aldosterone antagonist<ul><li>Already being used<li>Contraindications:  Female and most recent creatinine  >2(Female and most recent creatinine  >2[Sex(Female) && Creatinine(3.0/1967-4-10)])  Acitve prescription for ACE and ARB(Acitve prescription for ACE and ARB[ACE I being used && Presence of ARB]) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Beta Blocker Stage B no MI<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Captopril, Lisinopril, Enalapril)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction) </font><li>Relative contraindications:  Active prescription for ARB and aldosterone antagonist(Active prescription for ARB and aldosterone antagonist[Presence of ARB && presence of aldosterone antagonist]) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>ARB<ul><li>Already being used<li>Relative contraindications:  Active prescription for ACE and aldosterone antagonists(Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]) <li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomyopathy, Cardiomegaly, Heart_Failure)  Myocardial_Infarction(Myocardial_Infarction) <li>preference: ruled out</ul></ul></body></html>